AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2022
Apr 27, 2022
34301_dirs_2022-04-27_07132cd2-1a4a-4605-9ce2-0d598eed89ed.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2022-04-26
Reporting Person: Sims Andrew John Hugh MacIntyre (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-26 | Common Stock | P | 3000 | $0.672 | Acquired | 12230 | Direct |
More from PLUS THERAPEUTICS, INC.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27